Alaunos Therapeutics, Inc. Fair Value Adjustment of Warrants
Alaunos Therapeutics, Inc. (TCRT) reported Fair Value Adjustment of Warrants of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- Alaunos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Alaunos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- Alaunos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- Alaunos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $31.00K.
- Alaunos Therapeutics, Inc. fair value adjustment of warrants for fiscal 2025 was $31.00K.
- Alaunos Therapeutics, Inc. fair value adjustment of warrants for fiscal 2024 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $31.00K derived: sum of 3 quarters · filed 2026-08-14 | $31.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $31.00K derived: sum of 2 quarters · filed 2026-08-14 | $31.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $31.00K 10-Q · filed 2026-08-14 | $31.00K 10-Q · filed 2026-08-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |